Market Currents
Illumina (ILMN -1.2%) says its Board unanimously rejects Roche's (RHHBY.PK +2.3%) revised...
-
Monday, April 2, 2012, 2:28 PM ETIllumina (ILMN -1.2%) says its Board unanimously rejects Roche's (RHHBY.PK +2.3%) revised $51/share takeover offer, claiming the offer still undervalues ILMN and does not adequately reflect the company's singular position in an industry poised for extraordinary growth. (earlier)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
